107 employees
Leading North American Specialty Pharmaceutical Company focused on hematology, rheumatology, auto-immune disease, specialty oncology and pediatrics.
$30M sweet spot round size
2012
$30M
from investors over 1 rounds
Medexus Pharmaceuticals raised $30M on February 28, 2025